Has the Expert Committee of the Food and Drug Administration unanimously approved Eli Lilly's new drug? Will Alzheimer's patients have new choices?
楚一帆
发表于 2024-6-11 17:23:42
201
0
0
On June 10th, Lilly's Alzheimer's disease (AD) drug Donanemab was unanimously approved by the FDA's Advisory Committee on Peripheral and Central Nervous System Drugs (PCNS).
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- Three twists and turns! Altman's Return to OpenAI Frustrated Will Join Microsoft
- Will Altman join Microsoft OpenAI after being dismissed and replicate the Apple of the past
- Will Tesla's energy storage super factory be competitive in the domestic market of low price competition when it lands in China?
- US FDA Delays Approval of Eli Lilly's New Drug for Alzheimer's Disease
- Has the era of AI's iPhone begun? Altman targets AI hardware with a single image to understand his billion dollar investment empire
- Don't just focus on the storm caused by the strong US dollar: Will these stocks have opportunities on a global scale?
- After Tesla's two major super factories land in Shanghai Lingang in five years, will there be a third one for vehicle and energy storage?
- Eli Lilly's new drug for Alzheimer's disease, Kisumla, has been approved by the US FDA
- The second Alzheimer's disease drug approved by the United States: Eli Lilly R&D, with an annual treatment cost of $32000
- Eli Lilly's new Alzheimer's disease drug Donanemab has been approved for pricing in Japan
-
11월 14일, 세계예선 아시아지역 제3단계 C조 제5라운드, 중국남자축구는 바레인남자축구와 원정경기를 가졌다.축구 국가대표팀은 바레인을 1-0으로 꺾고 예선 2연승을 거두었다. 특히 이번 경기 국내 유일한 중계 ...- 我是来围观的逊
- 1 시간전
- Up
- Down
- Reply
- Favorite
-
"영비릉: 2024회계연도 영업수입 동기대비 8% 감소"영비릉은 2024회계연도 재무제보를 발표했다.2024 회계연도 매출은 149억5500만 유로로 전년 동기 대비 8% 감소했습니다.이익은 31억 500만 유로입니다.이익률은 ...- 勇敢的树袋熊1
- 3 일전
- Up
- Down
- Reply
- Favorite
-
계면신문기자 장우발 4분기의 영업수입이 하락한후 텐센트음악은 다시 성장으로 돌아왔다. 11월 12일, 텐센트음악은 최신 재보를 발표했다.2024년 9월 30일까지 이 회사의 3분기 총수입은 70억 2천만 위안으로 전년 ...
- 勇敢的树袋熊1
- 그저께 15:27
- Up
- Down
- Reply
- Favorite
-
본사소식 (기자 원전새): 11월 14일, 다다그룹 (나스닥코드: DADA) 은 2024년 3분기 실적보고를 발표했다. 수치가 보여준데 따르면 고품질발전전략에 지속적으로 전념하고 사용자체험을 끊임없이 최적화하며 공급을 ...- 家养宠物繁殖
- 어제 15:21
- Up
- Down
- Reply
- Favorite
